photo of

Details

Role Group Leader/Clinician-Scientist Fellow

Contact

Available for student supervision
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at the Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician and clinical pharmacologist as well as the Clinical Lead of Research in the Department of General Medicine at the Royal Children’s Hospital Melbourne. In addition, she is an Associate Professor in the Department of Paediatrics, at the University of Melbourne.

Her research program focuses on optimising antimicrobial use and access in children and includes national and international clinical trials, pharmacokinetic/pharmacodynamic studies, and cohort studies. Amanda is passionate about improving medication use in children and is therefore involved in several international guideline/expert groups (European Society for Paediatric Infectious Diseases, WHO, Therapeutic Guidelines). She created and leads the Australasian KIDS DOSE consortium, a network of paediatric clinician researchers across 17 hospital/research institutions in Australia and New Zealand, dedicated to improving equity in access to optimal antimicrobial use in children.
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at the Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician and clinical pharmacologist as well as the...
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at the Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician and clinical pharmacologist as well as the Clinical Lead of Research in the Department of General Medicine at the Royal Children’s Hospital Melbourne. In addition, she is an Associate Professor in the Department of Paediatrics, at the University of Melbourne.

Her research program focuses on optimising antimicrobial use and access in children and includes national and international clinical trials, pharmacokinetic/pharmacodynamic studies, and cohort studies. Amanda is passionate about improving medication use in children and is therefore involved in several international guideline/expert groups (European Society for Paediatric Infectious Diseases, WHO, Therapeutic Guidelines). She created and leads the Australasian KIDS DOSE consortium, a network of paediatric clinician researchers across 17 hospital/research institutions in Australia and New Zealand, dedicated to improving equity in access to optimal antimicrobial use in children.

Top Publications

  • Hume-Nixon, M, Graham, H, Russell, F, Mulholland, K, Gwee, A, Duke, T, Graham, H, Graham, S, Gray, A, Gwee, A, et al. Review of the role of additional treatments including oseltamivir, oral steroids, macrolides, and vitamin supplementation for children with severe pneumonia in low- and middle-income countries. Journal of Global Health 12: 10005 2024
    view publication
  • Wilkes, C, Subhi, R, Graham, HR, Duke, T, Graham, S, Gray, A, Gwee, A, von Mollendorf, C, Mulholland, K, Russell, F, et al. Continuous Positive Airway Pressure (CPAP) for severe pneumonia in low- and middle-income countries: A systematic review of contextual factors. Journal of Global Health 12: 10012 2024
    view publication
  • Reyburn, R, Maher, J, von Mollendorf, C, Gwee, A, Mulholland, K, Russell, F, Duke, T, Graham, H, Graham, S, Gray, A, et al. The impact of the introduction of ten- or thirteen-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal disease and carriage: A systematic literature review. Journal of Global Health 13: 05001 2024
    view publication
  • Silvester, E, Plover, C, Gwee, A. Switching antifungals drugs within the triazole drug class: a potential treatment approach to drug-related hepatotoxicity. 2024
    view publication
  • Holschier, J, Boast, A, Plover, C, Boyce, S, McNab, S, Curtis, N, Gwee, A. 475. "The Outcomes and Adverse Effects of COVID-19 Therapies in High-Risk Children". Open Forum Infectious Diseases 10(Supplement_2) : ofad500.545 2023
    view publication

Page 2 of 20